Ferrous Bisglycinate.

Copper is the cofactor for ferroxidase enzymes such as ceruloplasmin and hephaestin, which oxidize iron into the form that binds transferrin so it can leave the gut lining and move out of storage into the blood. Adequate copper therefore supports the body's normal transport and use of the iron that ferrous bisglycinate delivers.

Calcium competes with iron at the point of absorption, so a large calcium dose taken in the same sitting can lower how much iron the gut takes up from that meal or supplement. Spacing calcium a couple of hours away from an iron dose is the established way to keep one from blunting the other.

Iron and zinc are both divalent minerals that share uptake routes in the small intestine, so a high dose of one taken on an empty stomach can reduce how much of the other is absorbed. Taking them with food or at separate times eases that competition and supports normal absorption of both.

Iron supplies the raw material for the hemoglobin that fills red blood cells, while folate is needed for the DNA synthesis that lets those cells divide and mature. Because both are required to form red blood cells normally, iron and folate have been formulated together for generations.

Ascorbate keeps iron in the ferrous state and holds it in a soluble complex through the small intestine. The effect is smaller for a bisglycinate chelate, which already arrives protected, but it still moves in the same direction.

Vitamin A status supports the release of stored iron into circulation for red cell formation. Low vitamin A limits what a given iron intake delivers.

Riboflavin-derived FAD supports the reductase activity around iron handling and the release of iron from ferritin stores. Riboflavin status changes how much absorbed iron is used.

Pyridoxal phosphate is the cofactor for ALA synthase, the rate-setting first step of heme synthesis where iron is incorporated. The ring has to be built for iron to be used.

Iron fills the heme while B12 supports the DNA synthesis that lets red cell precursors divide. A shortfall in one caps the response to the other.

Manganese and ferrous iron compete for DMT1 at the brush border, so large doses interfere with each other. A glycine chelate is partly absorbed by a peptide route, which softens the competition rather than removing it.

Catechins bind free non-heme iron in the lumen into unabsorbable complexes. Iron already bound in a bisglycinate chelate is less exposed to that binding, so the interaction is real but blunted.

Curcumin chelates iron and lowers the pool available for absorption. The bisglycinate form shields some of its iron from that competition, which is a common reason to pick the chelate in polyphenol-heavy formulas.

Quercetin's catechol groups bind free iron into complexes that are poorly absorbed. The chelated form is less exposed than a ferrous salt but still shares the lumen with it.

Viscous fibre traps minerals in a gel and slows their release at the absorptive surface. Spacing iron away from a large fibre dose keeps uptake predictable.

Phytate is the main binder of non-heme iron in plant meals and phytase hydrolyses it, freeing that iron. The gain is smaller for a chelate, which resists phytate binding, but it still applies to the free iron in the meal.

Loose ferrous iron drives oxidation of membrane fats, and vitamin E intercepts that chain reaction inside membranes. The chelate leaves less loose iron than a ferrous salt, so the pairing matters less here than with sulfate.

Both deliver ferrous iron to the same transport step at the duodenal brush border, so taking them together does not add two independent absorption routes. A single iron dose also raises hepcidin for roughly a day, which limits what a second dose taken soon after can be absorbed. Total elemental iron across all sources is the number that matters, not the count of products.

Two glycine molecules form the chelate ring around the ferrous ion, and it is that ring that shields the iron from dietary binders in the gut lumen. The glycine is the ligand, not an accessory. Added free glycine does not extend the chelate, since the complex is stoichiometric and already formed before it is swallowed.

Lactoferrin is an iron-binding glycoprotein studied as an alternative route for delivering iron and as an influence on how iron is handled in the gut. Its binding affinity for ferric iron is high, so it can hold iron rather than release it at the brush border. The two are usually presented as alternative strategies rather than as a stack.

Certain Lactobacillus plantarum strains have been reported to raise measured non-heme iron absorption when given with an iron-containing meal. The proposed route is production of organic acids that keep iron soluble at intestinal pH. Absorption is a marker of uptake, not by itself a change in iron status.

Fermentable fructans are converted by colonic bacteria to short chain fatty acids, lowering luminal pH and keeping minerals in a soluble form. Human mineral balance work has focused mostly on calcium and magnesium, with iron studied less. The mechanism is the same for all three, which is why the pairing is proposed at a modest confidence.

Fructooligosaccharides ferment in the colon and acidify the lumen, which supports mineral solubility in the distal gut. Most iron absorption happens proximally, so any contribution here is secondary to what the duodenum takes up. The effect is mechanistically plausible and modest in size where it has been measured.

Galactooligosaccharides have been reported to raise measured non-heme iron absorption when co-administered with an iron dose. The proposed route is again colonic fermentation and lower luminal pH. This is an absorption marker measured with stable isotopes, not an iron status endpoint.

Ionic iron salts need an acidic gastric environment to stay soluble before they reach the duodenum. Bisglycinate is less dependent on that than ferrous sulfate, because the chelate ring holds the iron regardless of pH. Anyone whose gastric acidity is low gains more from the chelate structure than from an added acidifier.

Raising gastric pH reduces the solubility of ionic iron salts and lowers their absorption, which is a documented interaction for antacid-type agents. A chelated iron is less exposed to this because the ligand keeps the metal complexed. Separating the two by a few hours remains the practical handling.

Divalent metal transporter 1 carries iron, zinc, copper, manganese and magnesium, so a large dose of one divalent cation reduces the transporter capacity available to another taken at the same time. The competition is dose dependent and is most noticeable when both are given as isolated supplements on an empty stomach. Separating them removes the issue.

Tannins form insoluble complexes with non-heme iron in the gut lumen, which is the classic reason tea taken with a meal lowers measured iron absorption. A glycine chelate is designed to be less exposed to this, since the iron is already coordinated. The interaction is reduced rather than abolished, so timing still matters.

Casein phosphopeptides and the calcium that comes with dairy protein both bind iron and reduce its measured absorption from a meal. This is the practical reason iron is usually taken away from milk. Chelated forms are less affected than simple salts but not immune to it.

Activated charcoal adsorbs a wide range of compounds non-selectively in the gut lumen, including minerals and supplements taken alongside it. Anything intended for absorption should be separated from it by several hours. This is a general handling rule, not specific to iron.

Carotenoids have been reported to form soluble complexes with non-heme iron and to partly offset the inhibitory effect of phytate and polyphenols in test meals. The work is mostly stable-isotope absorption studies rather than status trials. Any contribution is smaller than that of ascorbate on the same meal.

Folate supplies the one-carbon units for thymidylate synthesis, which rapidly dividing red cell precursors consume heavily. Iron covers the haem side of the same cell. The two are routinely formulated together for this reason.

Lysine has been reported alongside iron in a small number of clinical reports as an adjunct where iron alone gave a limited response. The proposed route is amino acid chelation similar in principle to the glycine ligand. Evidence is limited and the direction of effect should be regarded as tentative.

Unabsorbed iron reaches the colon and shifts the composition of the microbiota, favouring some genera over others. Live cultures are studied both as a way to influence that shift and as an aid to absorption. The relationship is bidirectional and the human data is early.